The Pharma industry has been flat over the last week, but Pfizer has lost 6.2%. The past year has been better, since the industry has gained 12% in that time. Earnings are forecast to grow by 23% annually.
Has the U.S. Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 09 Aug 2024 | US$1.9t | US$359.8b | US$21.5b | 16.2x | 86.2x | 5.1x |
Sun, 07 Jul 2024 | US$2.0t | US$357.6b | US$13.8b | 15.1x | 141.8x | 5.5x |
Tue, 04 Jun 2024 | US$1.9t | US$358.3b | US$14.1b | 16.4x | 133.6x | 5.2x |
Thu, 02 May 2024 | US$1.8t | US$361.3b | US$18.4b | 23.5x | 99.6x | 5.1x |
Sat, 30 Mar 2024 | US$1.9t | US$355.3b | US$22.6b | 19.8x | 84.4x | 5.4x |
Mon, 26 Feb 2024 | US$1.9t | US$355.2b | US$24.0b | 24.1x | 80x | 5.4x |
Wed, 24 Jan 2024 | US$1.8t | US$361.7b | US$33.2b | 26.6x | 53.1x | 4.9x |
Fri, 22 Dec 2023 | US$1.6t | US$375.2b | US$33.9b | 26.6x | 48.6x | 4.4x |
Sun, 19 Nov 2023 | US$1.6t | US$375.1b | US$34.0b | 25.8x | 48x | 4.3x |
Tue, 17 Oct 2023 | US$1.7t | US$381.8b | US$43.8b | 16.9x | 39.3x | 4.5x |
Thu, 14 Sep 2023 | US$1.8t | US$381.8b | US$43.9b | 16.1x | 40x | 4.6x |
Sat, 12 Aug 2023 | US$1.8t | US$381.5b | US$43.9b | 18.7x | 40.2x | 4.6x |
Mon, 10 Jul 2023 | US$1.7t | US$392.8b | US$60.2b | 19x | 27.6x | 4.2x |
Wed, 07 Jun 2023 | US$1.7t | US$393.0b | US$60.5b | 18.8x | 28.3x | 4.4x |
Fri, 05 May 2023 | US$1.7t | US$392.9b | US$59.5b | 19.2x | 28.7x | 4.3x |
Sun, 02 Apr 2023 | US$1.6t | US$401.2b | US$69.5b | 15.1x | 22.7x | 3.9x |
Tue, 28 Feb 2023 | US$1.6t | US$401.8b | US$68.4b | 17.7x | 22.9x | 3.9x |
Thu, 26 Jan 2023 | US$1.7t | US$402.6b | US$69.4b | 17.6x | 24.4x | 4.2x |
Sat, 24 Dec 2022 | US$1.8t | US$403.7b | US$70.7b | 16.8x | 24.8x | 4.4x |
Mon, 21 Nov 2022 | US$1.7t | US$403.7b | US$70.6b | 14.2x | 24.4x | 4.3x |
Wed, 19 Oct 2022 | US$1.6t | US$403.0b | US$71.3b | 13.1x | 22.6x | 4x |
Fri, 16 Sep 2022 | US$1.6t | US$403.0b | US$71.3b | 13.7x | 22.2x | 3.9x |
Sun, 14 Aug 2022 | US$1.7t | US$403.0b | US$70.5b | 15.1x | 23.4x | 4.1x |
Tue, 12 Jul 2022 | US$1.7t | US$392.4b | US$65.1b | 22x | 26.2x | 4.3x |
Thu, 09 Jun 2022 | US$1.7t | US$392.5b | US$64.7b | 22.2x | 26.1x | 4.3x |
Sat, 07 May 2022 | US$1.6t | US$392.7b | US$62.9b | 20.5x | 25.7x | 4.1x |
Mon, 04 Apr 2022 | US$1.7t | US$373.8b | US$60.3b | 21.4x | 27.5x | 4.4x |
Wed, 02 Mar 2022 | US$1.5t | US$374.2b | US$60.1b | 21x | 25.2x | 4.1x |
Fri, 28 Jan 2022 | US$1.6t | US$363.7b | US$40.7b | 21.6x | 38.4x | 4.3x |
Sun, 26 Dec 2021 | US$1.7t | US$361.1b | US$37.9b | 22.6x | 43.7x | 4.6x |
Tue, 23 Nov 2021 | US$1.6t | US$360.7b | US$38.2b | 23.5x | 41.3x | 4.4x |
Thu, 21 Oct 2021 | US$1.5t | US$340.0b | US$24.9b | 21.3x | 61.1x | 4.5x |
Sat, 18 Sep 2021 | US$1.5t | US$337.6b | US$25.9b | 22.9x | 57.7x | 4.4x |
Mon, 16 Aug 2021 | US$1.6t | US$338.5b | US$25.8b | 21x | 62.7x | 4.8x |
62.7x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -2.33% | |
Healthcare | -1.30% | |
Pharma | -0.33% | |
Pharma | -0.33% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$845.31 | 1.5% +US$11.6b | 62.1% | PE124x | |
ZTS Zoetis | US$188.30 | 3.2% +US$2.1b | -0.4% | PE36.4x | |
MRK Merck | US$113.92 | 0.09% +US$481.5m | 7.9% | PE21x | |
HROW Harrow | US$33.92 | 38.2% +US$331.5m | 102.6% | PS7.8x | |
AMRX Amneal Pharmaceuticals | US$7.77 | 8.2% +US$182.1m | 83.7% | PS1x |